期刊文献+

改良自体巩膜包裹羟基磷灰石义眼台植入术后疗效及并发症及原因分析 被引量:4

Efficacies and complications of reformotive operation of hydroxyapatite orbital implants
下载PDF
导出
摘要 目的:分析改良自体巩膜包裹羟基磷灰石义眼台植入术后疗效及并发症,并探讨并发症发生原因。方法:回顾眼内容物剜除联合Ⅰ期改良自体巩膜包裹羟基磷灰石义眼台植入术32例,随诊1年以上。结果:32例中发生并发症的有4例(12.5%),其中义眼台暴露1例(3.13%),结膜创口哆开2例(6.25%),结膜肉芽肿1例(3.13%)。结论:眼内容物剜除联合Ⅰ期改良自体巩膜包裹羟基磷灰石义眼台植入术是安全有效的手术方式。通过规范手术程序等措施可以减少并发症的发生。 Objective To analyze the efficacies and complications of reforrnotive operation of hydroxyapatite orbital implants. Methods Clinical data of 32 patients underwent hydroxyapatite orbital implantation, who were followed-up for more than 1 year were retrospectively analyzed. Results Complications were observed in 4 cases (12.5%), of whom 1 case had implant exposure, 2 cases had fissure of conjunctiva, and another 1 case had conjunctival granuloma. Conclusion The reformotive operation of hydroxyapatite orbital implants is a safe and effective method for plastic operation of orbital cavity. Complications could be reduced by standardizing the operation procedures and other measures.
出处 《实用医学杂志》 CAS 北大核心 2012年第21期3604-3606,共3页 The Journal of Practical Medicine
关键词 羟基磷灰石类 植入 疗效 并发症 Hydroxyapatites Implant Curative effect Complications
  • 相关文献

参考文献5

二级参考文献29

  • 1陶明,张文方.两种义眼台植入方式的比较[J].眼外伤职业眼病杂志,2004,26(7):492-493. 被引量:7
  • 2翟文娟,韩梅,郭黎娅.羟基磷灰石义眼座眶内植入139例分析[J].眼外伤职业眼病杂志,2004,26(11):755-756. 被引量:11
  • 3陈涛,闵燕,李冬梅,赵颖,何玉良.同种异体脱细胞真皮替代同种异体巩膜在眼窝填充中的实验研究[J].中华整形外科杂志,2005,21(3):204-207. 被引量:3
  • 4杜刚,张虹.羟基磷灰石眶植入物纤维血管化的影响因素[J].眼外伤职业眼病杂志,2007,29(1):76-78. 被引量:7
  • 5陈蔷娟 廖洪斐 陈玲 等.羟基磷灰石义眼座眼眶植入术后球结膜裂开修补术[J].中华眼科杂志,2000,36(2):115-115.
  • 6Remulla HD,Peter AD,Shore JW,et al.Complications of porous spherical orbital implants[J].Ophthalmology,1995,102(4):586.
  • 7Buettner H,Bartley GB.Tissue break down and exposure associated with orbital hydroxyapatite implants[J].Am J Ophthalmol,1992,113(6):669.
  • 8Gupta M,Puri P,Rennie IG.Use of bovine pericardium as a wrapping material for hydroxyapatite orbital implants[J].Br J Ophthalmol 2002;86:288-289.
  • 9Shield CL,Shields JA,Eagle RC,De Potter P.Histopathologic evidence of fibrovascular in growth four weeks after placement of the hydroxyapatite orbital implant[J].Am J Ophthalmol 1991;111:363-366.
  • 10Liao SL,Kao SCS,Tseng JHS,Lin LL-K.Surgical coverage of exposed hydroxyapatite implant with retroauricular myoperiosteal graft[J].Br J Ophthalmol 2005;89(1):92-95.

共引文献68

同被引文献27

  • 1侯文明,司徒朴,王韦.羟基磷灰石复合材料的复合作用的研究[J].生物医学工程学杂志,1995,12(2):182-185. 被引量:25
  • 2聂玉红,邢怡桥,郭颖,朱晶.羟基磷灰石义眼台植入后暴露原因分析及处理[J].眼科新进展,2006,26(9):691-693. 被引量:38
  • 3林茂昌.HA义眼台Ⅰ期植入术后暴露原因分析及其预防[J].中国实用眼科杂志,2007,25(7):759-761. 被引量:20
  • 4Luetke A,Meyers P A, Lewis I,et al. Osteosarcoma treatment -where do we stand? A state of the art review [J]. Cancer TreatRev,2014,40(4) :523-532.
  • 5Giavaresi G, Fini M, Salvage J, et al. Bone regenerationpotential of a soybean-based filler: experimental study in arabbit cancellous bone defects [J]. J Mater Sci Mater Med,2010,2I(2):615-626.
  • 6Jaiswal A K, Dhumal H V,Ghosh S, et al. Bone healingevaluation of nanofibrous composite scaffolds in rat calvarialdefects : a comparative study [J]. J Biomed Nanotechnol, 2013,9(12):2073-2085.
  • 7Hiliaireau H , Couvreur P. Nanocarriers,entry into the cell :relevance to drug delivery [ J ]. Cell Mol Life Sci, 2009,66(17):2873-2896.
  • 8Roveri N, Palazzo Bt Iafisco M. The role of biomimetism indeveloping nanostructured inorganic matrices for drug delivery[J]. Expert Opin Drug Deliv,2008,5(8) :861-877.
  • 9Uchida A, Shinto Y, Araki N,et al. Slow release of anticancerdrugs from porous calcium hydroxyapatite ceramic [J]. J OrthopRes,1992,10(3):440-445.
  • 10赵光喜.眼部成形学[M].北京:人民军医出版社.1994:745-748.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部